Rapid legal triage for SEC trading suspensions, FINRA OTC halts, and OTC Markets risk designations, with a focus on disclosure, fact-finding, and remediation planning.
A trading halt or SEC trading suspension can be one of the most serious events a public company can face. Whether it is a FINRA “U3” Extraordinary Event halt, an OTC Markets “Caveat Emptor” designation, or a 10-business-day SEC trading suspension, the impact can be immediate: trading or quotations may be limited or suspended, shareholder concern can rise quickly, and the company’s reputation may be damaged. The public explanation may be limited, leaving management to move quickly to understand the concern and correct any inaccurate or incomplete disclosure.
At Ishimbayev Law Firm, we treat a trading halt as a regulatory emergency. We step in quickly to establish a disciplined communication channel between your executive team and the relevant regulators or market operators. We conduct rapid fact-finding, seek appropriate communication with the SEC or FINRA where needed, and execute a remediation strategy designed to clarify market confusion, address the concerns, and prepare for the next steps in the market.
Promptly assessing whether contact with the SEC, FINRA, OTC Markets, or other relevant parties is appropriate to understand the catalyst for the halt or suspension, such as suspected manipulation, delinquent filings, or questionable press releases.
Drafting and filing the necessary corrective Current Reports on Form 8-K or clarifying press releases that may be appropriate to address concerns regarding the accuracy or adequacy of publicly available information.
Trading suspensions can be accompanied by, or followed by, formal SEC investigations. We represent the company and its officers in responding to document requests and regulatory subpoenas.
After an SEC suspension ends, OTC quotation activity often does not simply return to normal. A broker-dealer may need to review current publicly available information and satisfy Rule 15c2-11 before publishing quotations again, and we help plan the requotation path, including market maker engagement and Form 211 considerations where required.
In a trading halt, hours matter. We execute a rapid-response protocol to assess the damage, preserve potentially relevant internal communications and records, and prepare a holding statement to help address investor concerns while we investigate the root cause.
When the SEC or FINRA takes action, there may be concerns about market integrity, disclosure, settlement, or investor protection. If management communicates without preparation, there is a risk of making incomplete, inaccurate, or unhelpful statements. We act as your specialized legal shield, helping manage communications with regulatory staff and reduce the risk of additional missteps.
For OTC issuers, a trading issue may also involve the “Skull and Crossbones” (Caveat Emptor) warning. We help conduct the internal review and prepare disclosure updates or supporting legal analysis that may be relevant to OTC Markets’ review of the designation.
In some microcap situations, trading issues may be connected to convertible note conversions, unusual deposits, or other market activity. We use the halt as an opportunity to review trading and financing data, identify the relevant counterparties or transactions, and evaluate legal options, restructuring approaches, or other steps that may address the underlying financing issues.
Under federal law, the SEC can suspend trading in any stock for up to 10 business days if the Commission determines that a suspension is required in the public interest and for the protection of investors. Common reasons include questions about the accuracy or adequacy of public information, concerns about promotional activity, or suspicions of insider trading or market manipulation.
The SEC suspension expires by its terms, but quotation and liquidity issues may remain. After an SEC suspension, broker-dealers generally may not publish quotations unless the Rule 15c2-11 requirements or an available exception are satisfied. The security may have limited or no quoted market until a compliant requotation process is completed. A market maker may need to complete the applicable requotation process, including Form 211 where required.
A U3 halt is issued by FINRA when it determines that an extraordinary event has occurred or is ongoing that has a material effect on the market, may cause major disruption, or creates significant uncertainty in the settlement and clearance process of an OTC equity security. The duration and any extension depend on FINRA’s determinations under its rule.
Kindly complete the form provided below
Download our FREE guide and take the
first step in building a successful business